Clinical Trials Browser

Phase 2 × Rifaximin × Thoracic × Clear all

NCT05502913 2023-10-02

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Phase 2 Recruiting

Lung Neoplasms